BDBM50115875 6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-phenyl]-1H-benzoimidazole-5-carboxamidine::CHEMBL62509

SMILES: C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O

InChI Key: InChIKey=PGCMJGUJHGYJLK-TXEJJXNPSA-N

Data: 5 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50115875   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Urokinase-type plasminogen activator (Homo sapiens (Human))	BDBM50115875 (6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-p...) Show SMILES C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| Show InChI InChI=1S/C21H23FN4O2/c1-11-5-7-12(8-6-11)28-18-4-2-3-13(19(18)27)21-25-16-9-14(20(23)24)15(22)10-17(16)26-21/h2-4,9-12,27H,5-8H2,1H3,(H3,23,24)(H,25,26)/t11-,12+	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Celera Curated by ChEMBL					Assay Description Inhibition of urokinase-type plasminogen activator				Bioorg Med Chem Lett 12: 2019-22 (2002) BindingDB Entry DOI: 10.7270/Q237782T
					More data for this Ligand-Target Pair
Plasminogen (Homo sapiens (Human))	BDBM50115875 (6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-p...) Show SMILES C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| Show InChI InChI=1S/C21H23FN4O2/c1-11-5-7-12(8-6-11)28-18-4-2-3-13(19(18)27)21-25-16-9-14(20(23)24)15(22)10-17(16)26-21/h2-4,9-12,27H,5-8H2,1H3,(H3,23,24)(H,25,26)/t11-,12+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	1.70E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Celera Curated by ChEMBL					Assay Description Inhibition of plasmin				Bioorg Med Chem Lett 12: 2019-22 (2002) BindingDB Entry DOI: 10.7270/Q237782T
					More data for this Ligand-Target Pair
Prothrombin (Homo sapiens (Human))	BDBM50115875 (6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-p...) Show SMILES C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| Show InChI InChI=1S/C21H23FN4O2/c1-11-5-7-12(8-6-11)28-18-4-2-3-13(19(18)27)21-25-16-9-14(20(23)24)15(22)10-17(16)26-21/h2-4,9-12,27H,5-8H2,1H3,(H3,23,24)(H,25,26)/t11-,12+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Celera Curated by ChEMBL					Assay Description Inhibition of thrombin				Bioorg Med Chem Lett 12: 2019-22 (2002) BindingDB Entry DOI: 10.7270/Q237782T
					More data for this Ligand-Target Pair
Coagulation factor X (Homo sapiens (Human))	BDBM50115875 (6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-p...) Show SMILES C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| Show InChI InChI=1S/C21H23FN4O2/c1-11-5-7-12(8-6-11)28-18-4-2-3-13(19(18)27)21-25-16-9-14(20(23)24)15(22)10-17(16)26-21/h2-4,9-12,27H,5-8H2,1H3,(H3,23,24)(H,25,26)/t11-,12+	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	3.80E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Celera Curated by ChEMBL					Assay Description Inhibition of Coagulation factor X				Bioorg Med Chem Lett 12: 2019-22 (2002) BindingDB Entry DOI: 10.7270/Q237782T
					More data for this Ligand-Target Pair
Tissue-type plasminogen activator (Homo sapiens (Human))	BDBM50115875 (6-Fluoro-2-[2-hydroxy-3-(4-methyl-cyclohexyloxy)-p...) Show SMILES C[C@H]1CC[C@H](CC1)Oc1cccc(-c2nc3cc(F)c(cc3[nH]2)C(N)=N)c1O |wD:4.7,1.0,(9.17,-1.34,;7.63,-1.36,;6.84,-.03,;5.3,-.05,;4.56,-1.4,;5.34,-2.73,;6.87,-2.71,;3.02,-1.43,;2.22,-.1,;2.97,1.25,;2.17,2.57,;.63,2.54,;-.11,1.19,;-1.65,1.17,;-2.54,-.09,;-4.01,.37,;-5.32,-.44,;-6.66,.32,;-7.99,-.47,;-6.69,1.86,;-5.37,2.64,;-4.03,1.91,;-2.58,2.4,;-8.04,2.61,;-9.37,1.81,;-8.06,4.14,;.68,-.12,;-.07,-1.48,)| Show InChI InChI=1S/C21H23FN4O2/c1-11-5-7-12(8-6-11)28-18-4-2-3-13(19(18)27)21-25-16-9-14(20(23)24)15(22)10-17(16)26-21/h2-4,9-12,27H,5-8H2,1H3,(H3,23,24)(H,25,26)/t11-,12+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	7.10E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Celera Curated by ChEMBL					Assay Description Inhibition of tissue-type plasminogen activator				Bioorg Med Chem Lett 12: 2019-22 (2002) BindingDB Entry DOI: 10.7270/Q237782T
					More data for this Ligand-Target Pair